These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15302104)

  • 1. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction.
    Edfeldt K; Bennet AM; Eriksson P; Frostegård J; Wiman B; Hamsten A; Hansson GK; de Faire U; Yan ZQ
    Eur Heart J; 2004 Aug; 25(16):1447-53. PubMed ID: 15302104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes.
    Kolek MJ; Carlquist JF; Muhlestein JB; Whiting BM; Horne BD; Bair TL; Anderson JL
    Am Heart J; 2004 Dec; 148(6):1034-40. PubMed ID: 15632890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events.
    Ameziane N; Beillat T; Verpillat P; Chollet-Martin S; Aumont MC; Seknadji P; Lamotte M; Lebret D; Ollivier V; de Prost D
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):e61-4. PubMed ID: 14563652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events.
    Boekholdt SM; Agema WR; Peters RJ; Zwinderman AH; van der Wall EE; Reitsma PH; Kastelein JJ; Jukema JW;
    Circulation; 2003 May; 107(19):2416-21. PubMed ID: 12742999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia.
    Newport MJ; Allen A; Awomoyi AA; Dunstan SJ; McKinney E; Marchant A; Sirugo G
    Tuberculosis (Edinb); 2004; 84(6):347-52. PubMed ID: 15525557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR2 Arg753Gly, TLR4 Asp299Gly and Thr399Ile gene polymorphisms are not associated with chronic periodontitis in a Turkish population.
    Berdeli A; Emingil G; Han Saygan B; Gürkan A; Atilla G; Köse T; Baylas H
    J Clin Periodontol; 2007 Jul; 34(7):551-7. PubMed ID: 17555409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism.
    van der Graaf C; Kullberg BJ; Joosten L; Verver-Jansen T; Jacobs L; Van der Meer JW; Netea MG
    Cytokine; 2005 Jun; 30(5):264-8. PubMed ID: 15927851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR4 Asp299Gly and Thr399Ile polymorphisms are very rare in the Chinese population.
    Hang J; Zhou W; Zhang H; Sun B; Dai H; Su L; Christiani DC
    J Endotoxin Res; 2004; 10(4):238-40. PubMed ID: 15373967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha promoter, Nod2 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin.
    Schippers EF; van 't Veer C; van Voorden S; Martina CA; le Cessie S; van Dissel JT
    Cytokine; 2004 Apr; 26(1):16-24. PubMed ID: 15016407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin.
    Schippers EF; van 't Veer C; van Voorden S; Martina CA; Huizinga TW; le Cessie S; van Dissel JT
    Cytokine; 2005 Mar; 29(5):215-28. PubMed ID: 15760678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between chronic periodontitis and the Toll-like receptor 4 gene polymorphisms in a Czech population.
    Izakovicova Holla L; Buckova D; Fassmann A; Roubalikova L; Vanek J
    J Periodontal Res; 2007 Aug; 42(4):340-4. PubMed ID: 17559631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation, longevity, and cardiovascular diseases: role of polymorphisms of TLR4.
    Candore G; Aquino A; Balistreri CR; Bulati M; Di Carlo D; Grimaldi MP; Listì F; Orlando V; Vasto S; Caruso M; Colonna-Romano G; Lio D; Caruso C
    Ann N Y Acad Sci; 2006 May; 1067():282-7. PubMed ID: 16803999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
    Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
    Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis.
    van der Paardt M; Crusius JB; de Koning MH; Morré SA; van de Stadt RJ; Dijkmans BA; Peña AS; van der Horst-Bruinsma IE
    Ann Rheum Dis; 2005 Feb; 64(2):235-8. PubMed ID: 15647432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lack of association between four point mutations in the promoter region of the toll-like 4 receptor gene and myocardial infarction.
    De Staercke C; Lally C; Austin H; Winston C; Dowling N; Williams B; Hooper WC
    Thromb Res; 2007; 119(1):105-10. PubMed ID: 16469362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of toll-like receptor 4 variants and ankylosing spondylitis: a case-control study.
    Snelgrove T; Lim S; Greenwood C; Peddle L; Hamilton S; Inman R; Rahman P
    J Rheumatol; 2007 Feb; 34(2):368-70. PubMed ID: 17143969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population.
    Lorenz E; Hallman M; Marttila R; Haataja R; Schwartz DA
    Pediatr Res; 2002 Sep; 52(3):373-6. PubMed ID: 12193670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study.
    Morange PE; Tiret L; Saut N; Luc G; Arveiler D; Ferrieres J; Amouyel P; Evans A; Ducimetiere P; Cambien F; Juhan-Vague I;
    Eur J Hum Genet; 2004 Dec; 12(12):1041-9. PubMed ID: 15367917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barré syndrome in Northern Indian population.
    Nyati KK; Prasad KN; Verma A; Singh AK; Rizwan A; Sinha S; Paliwal VK; Pradhan S
    J Neuroimmunol; 2010 Jan; 218(1-2):116-9. PubMed ID: 19913922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.